YD312

· YD Global Life Science Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YD312, covering 2020-01-09 to 2020-01-09. Get the full timeline:

Most recent: Clinical Trial Update: The Study to YD312 Tablet in Patients With Diabetic Macular Edema [Phase 2]